CALQUENCE CONFIDENCE
IN R/R MCL AT MEDIAN 26-MONTH FOLLOW-UP*
DEMONSTRATED SAFETY and
TOLERABILITY PROFILE
FEW DOSE REDUCTIONS and
DISCONTINUATIONS due to adverse events
CALQUENCE CONFIDENCE